Nagesha C Krishnappa1, Pratyusha Ganne1. Show Affiliations » 1. Aravind Eye Hospital, Puducherry, India.
Abstract
Entities: Disease Species
Mesh： See more » Angiogenesis Inhibitors/therapeutic useBevacizumab/therapeutic useBlood Protein ElectrophoresisDiabetes Mellitus, Type 2/diagnosisDiabetes Mellitus, Type 2/drug therapyDiabetes Mellitus, Type 2/physiopathologyDrug Therapy, CombinationGlucocorticoids/therapeutic useHumansIntravitreal InjectionsMaleMiddle AgedMultiple Myeloma/diagnosisMultiple Myeloma/drug therapyMultiple Myeloma/physiopathologyParaproteinemias/diagnosisParaproteinemias/drug therapyParaproteinemias/physiopathologyRetinal Diseases/diagnosisRetinal Diseases/drug therapyRetinal Diseases/physiopathologyStroke/diagnosisStroke/physiopathologyTriamcinolone Acetonide/therapeutic useVascular Endothelial Growth Factor A/antagonists & inhibitorsVision Disorders/diagnosisVision Disorders/drug therapyVision Disorders/physiopathologyVisual Acuity/physiology
Substances： See more » Angiogenesis InhibitorsGlucocorticoidsVEGFA protein, humanVascular Endothelial Growth Factor ABevacizumabTriamcinolone Acetonide
Year: 2018 PMID： 29801030 DOI： 10.1001/jamaophthalmol.2017.6285
Source DB: PubMed Journal: JAMA Ophthalmol ISSN： 2168-6165 Impact factor: 7.389